The Overactive Bladder: Evaluation and Management

Summary

Overactive bladder (OAB) affects millions of men and women daily. Given the symptoms of sleep loss, depression, and a lower quality of life than even those with diabetes mellitus, effective and beneficial treatment is a must for these people. Drs Kreder and Dmochowski, both recognized experts on voiding dysfunction and urodynamics, have assembled a distinguished team of experts from around the globe to share with the reader, whether qualified or in training, their perspectives based both on best practice and personal experience in evaluating and managing the overactive bladder. This seminal work should guide the reader in daily practice.

Contents

• 1. Nomenclature
• 2. The Neurophysiology of Lower Urinary Tract Function
• 3. The Diagnosis of Overactive Bladder
• 4. Measuring Oab Symptoms
• 5. Nocturia
• 6. Urodynamics
• 7. Urgency/Frequency Syndome/ Interstitial Cystitis
• 8. Pelvic Floor Muscle Exercises/Behavioral Therapy
• Section 2, Pharmacology
  • 9.Basic Pharmacology
  • 10. Drug Delivery &amp Intravesical Instillation
  • 11. Pioneering Agents (Immediate-Release)
  • 12. Tricyclic Antidepressants
  • 13. Propiverine
  • 14. Oxybutynin
  • 15. Tolterodine
  • 16. Trospium
  • 17. Darifenicin
  • 18. Solifenacin
  • 19. Oxytrol
  • 20. Comparing Antimuscarinics
  • 21. Pharmacotx in Men W/ Oab &amp Boo
  • 22. Botulinum Toxin (Botox)
  • 23. Acupuncture
  • 24. Fesoterodine
• Section 3, Neuromodulation
  • 25. Neuromodulation (Mechanism of Action)
  • 26. Interstim, Including Malfunctioning Interstim
  • 27. Bion
  • 28. Miniaturo-I
• Section 4, Surgical Therapy
  • 29. Transvaginal Denervation
  • 30. Autoaugmentation
  • 31. Augmentation Cystoplasty
• Section 5, Special Considerations
  • 32. Pediatric Population
  • 33. Geriatric Population
  • 34. Late Breaking Information